Serum IgE as an immunological marker to predict response to omalizumab treatment in symptomatic chronic urticaria

J Allergy Clin Immunol Pract. 2018 Jul-Aug;6(4):1386-1388.e1. doi: 10.1016/j.jaip.2017.10.030. Epub 2017 Nov 23.
No abstract available

Publication types

  • Letter
  • Multicenter Study
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Anti-Allergic Agents / therapeutic use*
  • Biomarkers, Pharmacological / blood*
  • Chronic Disease
  • Female
  • Humans
  • Immunoglobulin E / blood*
  • Male
  • Middle Aged
  • Omalizumab / therapeutic use*
  • Predictive Value of Tests
  • Prognosis
  • Retrospective Studies
  • Treatment Outcome
  • Urticaria / diagnosis*
  • Urticaria / drug therapy

Substances

  • Anti-Allergic Agents
  • Biomarkers, Pharmacological
  • Omalizumab
  • Immunoglobulin E